MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-10-0021291
Kuresys Labs Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹4.26 Cr
▼ 6% YoY
Net loss · FY 2025
₹16.06 Lakh
Net margin -3.8%
EBITDA · FY 2025
-₹7.31 Lakh
EBITDA margin -1.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹75 Lakh
Satisfied ₹75 Lakh
Company age
12 yrs
Est. 2014
Employees · EPFO
37
Provident fund records
About Kuresys Labs Private Limited
Data last updated:
Kuresys Labs Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 March 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2014PTC266735. Its GSTIN is 07AAFCK4941G1ZJ (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Anamika Keswal and Ranjit Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Eros Metro Mall Unit No. Sf – 06 Second Floor, Plot No. 8 Sector – 14 Dwarka, New Delhi, Delhi, India – 110078.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.26 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net loss of ₹16.06 Lakh (net margin -3.8%) and EBITDA of -₹7.31 Lakh (EBITDA margin -1.7%). Revenue has declined at a compounded annual rate (CAGR) of 15% over three years and 8% over five years.
The company has about 37 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Kuresys Labs. As per MCA filings, the company has open charges of ₹75 Lakh and satisfied charges of ₹75 Lakh on record. Court records list 4 cases involving the company, including 4 filed against it; 4 cases are pending.
Kuresys Labs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-10-0021291). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kuresys.com.
Company Details of Kuresys Labs Private Limited
CIN U24100DL2014PTC266735
Registration Number 266735
Incorporation Date 21 March 2014
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-10-0021291
Key People
Anamika Keswal Director Ranjit Singh Director Recognitions & Rankings of Kuresys Labs
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressEros Metro Mall Unit No. Sf – 06 Second Floor, Plot No. 8 Sector – 14 Dwarka, New Delhi, Delhi, India – 110078
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Kuresys Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Kuresys Labs Private Limited
Kuresys Labs operates one associated brand: KURESYS LABS. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality finished dosage form products for the pharmaceutical industry. | kuresyslabs.com |
Business Activity of Kuresys Labs Private Limited
The main business activity of Kuresys Labs is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Kuresys Labs Private Limited FY 2025 filings available
Kuresys Labs Private Limited reported revenue of ₹4.26 Cr (down 6% YoY) for FY 2025.
Revenue · FY 2025
₹4.26 Cr ▼ 6%
Net loss · FY 2025
₹16.06 Lakh margin -3.8%
EBITDA · FY 2025
-₹7.31 Lakh margin -1.7%
Compounded Annual Growth Rate (CAGR) of Kuresys Labs Private Limited
Revenue CAGR growth
1 year
▼ 6%
3 years · compounded
▲ 15%
5 years · compounded
▼ 8%
EBITDA CAGR growth
1 year
▼ 135%
3 years · compounded
▼ 36%
5 years · compounded
▼ 19%
Revenue has declined at a compounded annual rate (CAGR) of 8% over five years, including a 6% fall in the latest year. EBITDA fell 135% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Kuresys Labs Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹7.31 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹16.06 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Kuresys Labs Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -3.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Kuresys Labs are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Kuresys Labs Private Limited
Kuresys Labs has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anamika Keswal | Director | 26 Apr 2021 | 5 Years 5 Months | Current |
| Ranjit Singh | Director | 21 Mar 2014 | 12 Years 6 Months | Current |
Peer Comparison of Kuresys Labs Private Limited
Kuresys Labs Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Connectlife Pharma Private Limited | ₹4.28 Cr (FY 2024) | •••• | •••• | -22.0% | •••• | New Delhi, Delhi, India |
| Midway Pharmaceuticals Private Limited | ₹4.28 Cr (FY 2023) | •••• | •••• | 87.0% | •••• | Delhi, India |
| Bioves Pharmaceutical Private Limited | ₹4.28 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Hyderabad, Telangana, India |
| Remedial Healthcare India Private Limited | ₹4.27 Cr (FY 2024) | •••• | •••• | 16826133.0% | •••• | Ambala, Haryana, India |
| Rani Life Sciences Private Limited | ₹4.26 Cr (FY 2024) | •••• | •••• | -41.0% | •••• | Hyderabad, Telangana, India |
| Kuresys Labs Private Limited this company | ₹4.26 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | New Delhi, Delhi, India |
| VV Labs Private Limited | ₹4.26 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Hyderabad, Telangana, India |
| Zenwick Pharma Private Limited | ₹4.25 Cr (FY 2025) | •••• | •••• | 66.0% | •••• | Maliankara P.O, Ernakulam, Kerala, India |
| Abibba Pharmaa Private Limited | ₹4.24 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Chandigarh, India |
| Vsaar Pharma Private Limited | ₹4.24 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Chandigarh, India |
| Kobun Techno Pharma (OPC) Private Limited | ₹4.24 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Ranchi, Jharkhand, India |
Peers are the five companies nearest above and the five nearest below Kuresys Labs by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Kuresys Labs Private Limited
Kuresys Labs Private Limited is audited by TARUN KANDHARI & Co LLP for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| TARUN KANDHARI & Co LLP | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Kuresys Labs Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Kuresys Labs Private Limited
Open charges
₹75 Lakh
Satisfied charges
₹75 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Apr 2023 | Others | ₹75 Lakh | Satisfied |
Total charge records: 1 View all charges
Legal Cases of Kuresys Labs Private Limited
Kuresys Labs Private Limited has 4 court cases on record: 4 filed against it. All cases are pending. Status as checked on 29 Sep 2026.
Total cases
4
Filed against the company
4
Pending
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 4 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Central, Delhi | Court case (L I R) | Filed against the company by an individual | Pending |
| District court, Central, Delhi | Court case (L I R) | Filed against the company by an individual | Pending |
| District court, Central, Delhi | Court case (L I R) | Filed against the company by an individual | Pending |
| District court, Central, Delhi | Court case (L I R) | Filed against the company by an individual | Pending |
Premium access
Full case history
All 4 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Kuresys Labs Private Limited
Kuresys Labs Private Limited has a workforce of 37 employees as of Apr 03, 2024.
Employee count
37
Active EPFO establishments
1
Employee growth
48%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Kuresys Labs Private Limited
Kuresys Labs Private Limited has 5 board changes on record since 2014: 2 appointments and 3 cessations. The latest: Anamika Keswal was appointed as Director on 26 Apr 2021.
Charges
A charge registered on 26 Apr 2023 via Charge ID 100717104 with Others was fully satisfied on 09 Dec 2025.
AGM
Kuresys Labs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Kuresys Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Charges
A charge with Others amounted to Rs. 75.00 Lakh with Charge ID 100717104 was registered on 26 Apr 2023.
Appointed
Anamika Keswal was appointed as Director.
Ceased
Anju Bala ceased to be Director.
Ceased
Pawan Kumar Pandey ceased to be Director.
Ceased
Vinod Kumar Sharma ceased to be Director.
Appointed
Ranjit Singh was appointed as Director.
Incorporation
21 Mar 2014
Kuresys Labs Private Limited was registered on 21 Mar 2014 with Roc Delhi I & aged 12 years 7 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Kuresys Labs Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Kuresys Labs Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Kuresys Labs Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Kuresys Labs Private Limited
Kuresys Labs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCK4941G1ZJ | Delhi | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Kuresys Labs Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kuresys Labs Private Limited
Kuresys Labs is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 March 2014 (12+ years old) and is registered under CIN U24100DL2014PTC266735.
Kuresys Labs reported revenue of ₹4.26 Cr for FY 2025 (down 6% YoY).
Kuresys Labs has 2 current directors:
- Anamika Keswal - Director
- Ranjit Singh - Director
Kuresys Labs reported a net loss of ₹16.06 Lakh (net margin -3.8%) and EBITDA of -₹7.31 Lakh (EBITDA margin -1.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Kuresys Labs is 15% over three years and -8% over five years. In the latest year (FY 2025) revenue fell 6%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Kuresys Labs is 07AAFCK4941G1ZJ, registered in Delhi.
The CIN (Corporate Identification Number) of Kuresys Labs is U24100DL2014PTC266735. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kuresys Labs has 4 court cases on record: 4 filed against it. 4 are pending.
Kuresys Labs was incorporated on 21 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Kuresys Labs by revenue are Connectlife Pharma Private Limited, Midway Pharmaceuticals Private Limited, Bioves Pharmaceutical Private Limited, Remedial Healthcare India Private Limited, Rani Life Sciences Private Limited and 5 more, all in the Pharma industry (Formulations).
Anamika Keswal was appointed as Director on 26 Apr 2021. Anju Bala ceased to be Director on 26 Apr 2021. Pawan Kumar Pandey ceased to be Director on 27 Jul 2015. Kuresys Labs has 5 board changes on record in total.